Answers are grounded in this paper and cite their sources.
Ten patients with mild to severe Alzheimer's disease were treated for up to 10 months with 10 to 15 mg oral physostigmine daily or with placebo, according to a single blind, multiple crossover protocol. No clinically meaningful improvement occurred with physostigmine treatment.
No takes yet. Share an insight, caveat, or question.
Seymour Jotkowitz (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: